Influenza A M2 Protein Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Influenza A M2 Protein Inhibitor
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strides Pharma | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 209047-001 | Jun 7, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs Inc | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 208096-001 | Dec 15, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 208278-001 | May 31, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Strides Pharma | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 209035-001 | Jun 9, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
